Analysts recommendations

Generali: In his latest research note, analyst Farooq Hanif confirms his negative recommendation. The broker Credit Suisse is keeping its Sell rating. The target price has been lifted and is now set at EUR 14 compared to EUR 12.50 before.

Evotec: Analyst Charles Weston from RBC research considers the stock attractive and recommends it with a Buy rating. The target price is revised upwards from EUR 32 to EUR 30.

Safran: Berenberg increases his rating from Neutral to Buy. The target price is reviewed upwards from EUR 98 to EUR 140.

Deutsche Boerse: In a research note published by Thorsten Wenzel, DZ Bank advises its customers to buy the stock.

Rolls-Royce: Chris Hallam from Goldman Sachs retains his positive opinion on the stock with a Buy rating. The target price differs slightly and is now set at GBX 127 versus GBX 125.

K+S: Sven Diermeier from Independant Research retains his Neutral opinion on the stock. The target price has been revised upwards and is now set at EUR 7.20, compared with EUR 6.10 previously.

ThyssenKrupp: JP Morgan reiterate its Sell rating. The target price is unchanged and still at EUR 5.30.

Apple: Goldman Sachs is negative on the stock with a Sell rating. The target price continues to be set at USD 75.

BMW: In his latest research note, analyst Jose Asumendi confirms his positive recommendation. The broker JP Morgan is keeping its Buy rating. The target price is unchanged at EUR 80.

CRH: Credit Suisse analyst Lars Kjellberg maintains his Buy rating on the stock. The target price is still set at EUR 41.

AstraZeneca: In a research note, Berenberg analyst Luisa Hector has maintained his recommendation on the stock with a Buy rating. The target price remains unchanged at GBX 10500.